Signed in · PRO
ResMed / Full history

Guidance history, every release

ResMed (RMD) · 8 releases, Oct 24, 2024 to Aug 6, 2026 · rows are metrics, columns are releases
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
MetricOct 24, 2024
FY25 Q1
Jan 30, 2025
FY25 Q2
Apr 23, 2025
FY25 Q3
Jul 31, 2025
FY25 Q4
Oct 30, 2025
FY26 Q1
Jan 29, 2026
FY26 Q2
Apr 30, 2026
FY26 Q3
Aug 6, 2026
FY26 Q4
For FY2030
Ambition - people helpedNew“more than 500 million people”———————
For FY2027
Capital to be returned to shareholders through share repurchases and dividends———————New“more than $1.85 billion”
Quarterly dividend———————New“$0.66 per quarter”
For FY2026
Quarterly cash dividend—————New“$0.60 per share”Reiterated“$0.60 per share”—
For FY2025
Quarterly cash dividend—New“$0.53 per share”Reiterated“$0.53 per share”Raised“$0.60 per share”Reiterated“$0.60 per share”———
For FY2024
Quarterly cash dividendNew“$0.53 per share”———————
No period stated
Quarterly cash dividend———————New“$0.66 per share”
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.